In response to a mass resignation of trainee physicians that has led to significant medical disruptions, the Korean government said it would spend 200 billion won ($150.1 million) per month into the healthcare system to maintain emergency and patient care.The Ministry of Health and Welfare on Thursd
Samsung Pharm has received approval from the Ministry of Food and Drug Safety (MFDS) to change the investigative new drug (IND) application for its phase 3 clinical trial of GV1001 for Alzheimer's disease.The MFDS accepted Samsung Pharm's application to simplify GV1001's dosing regimen, approving a
Shaperon, a Korean biotech company, said Thursday that it has completed enrollment of the first patient in its U.S. phase 2 clinical trial of NuGel for treating atopic dermatitis.The trial is designed to evaluate NuGel in 210 patients of various ethnicities with mild to moderate atopic dermatitis fo
The 10th Cancer Disease Review Committee (CDRC), under the Health Insurance Review and Assessment Service (HIRA), held its first meeting with newly reconstituted members on Wednesday, during which it discussed nine new and expanded reimbursement proposals.However, most drugs did not pass the review,
In a significant milestone marking the ten-year collaboration between SK bioscience and Sanofi, a global leader in healthcare, the two companies have embarked on an ambitious expansion of the L HOUSE, SK bioscience’s vaccine manufacturing plant in Andong, North Gyeongsang Province.This expansion aim
Concerns are mounting that the government’s push to increase medical school enrollment quota could trigger “medical school craze” among office workers.Some private educational institutions, called hagwon in Korean, and online lecturing firms are “encouraging” office workers to study and apply to med
My Feb. 22 post on X, formerly Twitter, garnered 412,000 views, 723 retweets, and 709 likes as of March 1 at noon. Two days before Daeboreum, a Korean holiday commemorating the first full moon of the New Lunar Year, I shared a brief insight into its significance and attached a photo showcasing tradi
A team of researchers led by Professor Kim Sung-won of the Catholic University of Korea College of Medicine has successfully implanted the "world's first" customized and 3D-bioprinted artificial trachea based on another person's adult stem cells for a patient with an intractable tracheal defect, Cat
University hospitals are grappling with financial difficulties amid prolonged walkouts by trainee doctors, medical sources said.These hospitals have cut back on medical services due to the exodus of interns and residents. As the collective action enters the third week, declining revenue is leading t
Samsung Biologics said Tuesday that it has signed a contract manufacturing agreement worth 381.9 billion won ($352.79 million, based on USD/KRW 1,082.90 on Dec. 21, 2017) with Belgium-based UCB. The contract is an extension of a $41.65 million contract signed with the Belgian company in 2017.UCB is
Curocell, a Kosdaq-listed biotech company, said it received the topline data from its phase 2 clinical trial for its CAR-T (chimeric antigen receptor-T) therapy, Anbal-cel, to treat diffuse large B-cell lymphoma (DLBCL).The study is Korea's first clinical trial of a CAR-T therapy, involving 79 adult
HLB Group has announced the acquisition of domestic rights to Jiangsu Hengrui Pharmaceuticals' immunotherapy, camrelizumab, facilitating the path towards commercializing the combination therapy of camrelizumab and its novel drug candidate riboceranib in Korea.The group's subsidiaries -- HLB Life Sci
Multiple sclerosis (MS) is a rare, intractable disease whose symptoms are caused by damage to the myelin sheath that surrounds the nerve fibers called axons that run throughout the body, including the brain, spinal cord, and optic nerves. When the myelin sheath is damaged, the axons are exposed to t
Canon Korea has signed a medical device transaction contract with Johnson & Johnson MedTech Korea.Through the agreement, Canon Korea has acquired the rights to distribute Johnson & Johnson MedTech Korea's DePuy Synthes joint implants, which are used in orthopedics.The two companies held a business a
Pancreatic cancer is a very poorly treatable cancer. The cure rate (five-year survival rate) for pancreatic cancer is only 13.9 percent. The exact cause of pancreatic cancer, which is most common in people in their 60s and 70s, is still unknown.However, it is well known that smokers, people with dia
A 20-something job seeker surnamed Kang recently noticed that his hair was thinning, and his hairline became more noticeable than before. Kang thought it was due to the stress of his recent job search but couldn’t help but notice his hair falling out every time he washed and combed it. During a visi
Boston Scientific is recalling its medical device, a hemostasis valve-attached catheterizer, in Korea.According to the Ministry of Food and Drug Safety, Boston Scientific Korea submitted a recall plan for the hemostasis valve-attached catheterizer on Feb. 19 and began recalling the device.Sixty-two
Osang Healthcare said it recorded a 2,126 to 1 competition ratio in the company’s public share subscription for retail investors on Monday and Tuesday. The subscription deposit amounted to about 5.26 trillion won ($39.3 billion).Osang Healthcare's five-day demand forecast from Feb. 21 to 27 attracte
Patients and the pharmaceutical industry pay keen attention to whether the government will reimburse Enhertu (trastuzumab deruxtecan), for which drug price negotiations are underway with the National Health Insurance Service (NHIS) from April.Patient organizations have been pressuring the government
Professors at 33 Korean medical schools have filed a lawsuit to cancel the government's plan to increase in medical school student quotas. The defendants are the minister of health and welfare and the minister of education.Representatives of the faculty councils of 33 medical schools nationwide said